Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers
Clinical trial NCT04911660 · COMPLETED
Trial details
- NCT number
- NCT04911660
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-25
- Primary completion
- 2023-03-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.